1 IDEA-FAST Goals
identifying novel digital measures for fatigue and sleep disturbances that will provide more objective, sensitive and reliable measures of the severity and impact of these symptoms in the person’s normal surrounding.
2 Clinical Validation Study
one year longitudinal study with approximately 2000 subjects will be conducted
6 Data Collection
Data on fatigue, sleep, selected activities of daily living and other relevant contextual information will be collected by smartphone several times a day while using the devices
7 Data Analysis
In order to establish which devices are suitable for use, complex data analysis will be performed
8 Validation of devices
The devices that met the criteria will be considered for future use in clinical trials
9 Share & Use
The novel clinically validated digital endpoint will be able to:
- offer deeper insight into disease impact
- lead to faster clinical development of new therapies
- provide a more valid and complete assessment of the impact of diseases and treatments
Latest News
Enhancing the monitoring and evaluation of sleep
A study involving a key member of the IDEA-FAST [1] consortium presents new benchmarks to support the continued development of systems that enable healthcare practitioners to better manage patients with sleep disorders. The findings, [...]
Update on data management platform
The IDEA-FAST data management platform first release is now live. The platform has been deployed and is ready to receive data collected from the Feasibility Study.
Getting started with the Feasibility Study
After the successful Kick-Off meeting in Newcastle in February, the IDEA-FAST team worked hard to make the vision of the feasibility study come to life. Thanks to the device testing team, we were able [...]
IDEA-FAST Kick-Off Meeting
The project kick-off meeting was organised by Newcastle University and was held at the Newcastle United Football Club. Fai Ng and Fred Baribaud described the concept & approach for the project and strategies for identifying [...]
Press Release
Newcastle upon Tyne, February 05, 2019 – A new European research project to Identify Digital Endpoints to Assess FAtigue, Sleep and acTivities of daily living (acronym: IDEA-FAST) in the following neurodegenerative disorders (NDD): Parkinson’s disease [...]
We want to better understand #fatigue. That’s why we’re working with patient specialists to test some digital health technologies and help us analyse the data. Thank you to everyone who has joined our #featureengineering group to support this. @ParkinsonsUK @EFPIA @IMI2_NEURONET https://t.co/32GO8vVV49
Our Newcastle and Münster sites have received ethical approval to commence their feasibility study and are now preparing for their first participants.
@ParkinsonsUK
@EFPIA
@IMI2_NEURONET
The IDEA-FAST data management platform first release is now live. The platform has been deployed and is ready to receive data collected from the Feasibility Study. @ParkinsonsUK @EFPIA @IMI2_NEURONET
